Stock Events

Stock Events

Goldenwell Biotech 

$0.6500
2
+$0.05+8.33%Monday 18:29

Statistics

Day High
0.65
Day Low
0.65
52W High
7
52W Low
0.2
Volume
205
Avg. Volume
58
Mkt Cap
64.35M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
2025
0Revenue
-296,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotechnology firm focused on human therapeutics, competing in similar biotech sectors as Goldenwell Biotech.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences operates in the biopharmaceutical field, directly competing with Goldenwell Biotech in drug development and innovation.
Biogen
BIIB
Mkt Cap32.49B
Biogen focuses on neurological diseases and advanced therapies, overlapping with Goldenwell's biotech research areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals is known for creating treatments for serious diseases, competing with Goldenwell in cutting-edge biotech solutions.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals is involved in inventing medicines for serious medical conditions, similar to Goldenwell Biotech's mission.
Illumina
ILMN
Mkt Cap41.23B
Illumina provides genomics solutions, competing with Goldenwell Biotech in the biotechnological applications of genomic research.
Incyte
INCY
Mkt Cap23.37B
Incyte specializes in oncology and inflammation, competing in therapeutic areas that overlap with Goldenwell Biotech's interests.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.07B
BioMarin Pharmaceutical targets rare genetic diseases, competing in niche markets similar to Goldenwell Biotech's focus areas.

About

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Show More
CEO
Shuang Liu
Employees
3
Country
United States
ISIN
US38138N1046

Listings

OTC Link
US
GWLL

0 Comments

Share your thoughts

FAQs

What is Goldenwell Biotech stock price today?▼
The current price of GWLL is $0.65 USD — it has increased by +8.33% in the past 24 hours. Watch Goldenwell Biotech stock price performance more closely on the chart.
What is Goldenwell Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Goldenwell Biotech stocks are traded under the ticker GWLL.
Is Goldenwell Biotech stock price growing?▼
GWLL stock has risen by +0% compared to the previous week, the month change is a -5.76% fall, over the last year Goldenwell Biotech has showed a -90.71% decrease.
What is Goldenwell Biotech market cap?▼
Today Goldenwell Biotech has the market capitalization of 64.35M
What is Goldenwell Biotech revenue for the last year?▼
Goldenwell Biotech revenue for the last year amounts to 0 USD.
What is Goldenwell Biotech net income for the last year?▼
GWLL net income for the last year is -296,000 USD.
How many employees does Goldenwell Biotech have?▼
As of November 1, 2026, the company has 3 employees.
In which sector is Goldenwell Biotech located?▼
Goldenwell Biotech operates in the Health & Wellness sector.
When did Goldenwell Biotech complete a stock split?▼
Goldenwell Biotech has not had any recent stock splits.
Where is Goldenwell Biotech headquartered?▼
Goldenwell Biotech is headquartered in Solon, United States.